| European Society of Hypertension position paper on renal denervation 2021 | Journal of Hypertension | 2021 | 21 |
| Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia | Heart Lung and Circulation | 2021 | 20 |
| Lipoprotein(a): Knowns, unknowns and uncertainties | Pharmacological Research | 2021 | 12 |
| Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry | Heart Lung and Circulation | 2021 | 6 |
| Device Therapy of Hypertension | Circulation Research | 2021 | 6 |
| Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease | JACC: Cardiovascular Imaging | 2021 | 5 |
| Applications of machine learning to undifferentiated chest pain in the emergency department: A systematic review | PLoS ONE | 2021 | 5 |
| Coronary F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome | Atherosclerosis | 2021 | 4 |
| Gender difference in lipoprotein(a) concentration as a predictor of coronary revascularization in patients with known coronary artery disease | Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids | 2021 | 4 |
| Combined epicardial and endocardial ablation for atrial fibrillation: Best practices and guide to hybrid convergent procedures | Heart Rhythm | 2021 | 4 |
| The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis | Current Medicinal Chemistry | 2021 | 4 |
| Microvascular changes at different stages of chronic kidney disease | Journal of Clinical Hypertension | 2021 | 3 |
| Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population | Atherosclerosis | 2021 | 3 |
| Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a) | Atherosclerosis | 2021 | 3 |
| Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis | European Heart Journal | 2021 | 3 |
| Effectiveness of proprotein convertase subtilisin/kexin-9 monoclonal antibody treatment on plasma lipoprotein(a) concentrations in patients with elevated lipoprotein(a) attending a clinic | Clinical Cardiology | 2021 | 3 |
| Investigating the effect of an education program on diabetes and lipid lowering medication usage following coronary artery bypass graft surgery | Internal Medicine Journal | 2021 | 3 |
| Bexagliflozin for type 2 diabetes: an overview of the data | Expert Opinion on Pharmacotherapy | 2021 | 3 |
| A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort | European Journal of Preventive Cardiology | 2021 | 2 |
| Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3 | Future Cardiology | 2021 | 2 |
| Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel | Journal of Clinical Medicine | 2021 | 2 |
| Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes | Bioscience Reports | 2021 | 2 |
| Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first-line antihypertensive therapy | Journal of Clinical Hypertension | 2021 | 2 |
| Lipoprotein(a) in Patients With Type 2 Diabetes and Premature Coronary Artery Disease in the Coronary Care Unit | Heart Lung and Circulation | 2021 | 2 |
| Supine blood pressure-A clinically relevant determinant of vascular target organ damage in hypertensive patients | Journal of Clinical Hypertension | 2021 | 2 |
